Related Experiment Video
Updated: Jun 12, 2026

09:06
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Single-cell T-cell landscape in atherosclerosis: implications for targeted therapy and beyond.
Renfei Luo1, Shixing Liu1, Xin Ouyang1
1Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Journal of Translational Medicine
|June 11, 2026
Summary
Single-cell technologies reveal diverse T-cell subsets in atherosclerosis, showing their adaptability and plasticity. These findings pave the way for targeted immunotherapies and precision diagnostics for atherosclerosis patients.
Area of Science:
- Immunology
- Cardiovascular Research
- Genomics
Background:
- Atherosclerosis (AS) progression is significantly impacted by the complex and changing nature of T-cells.
- Understanding T-cell heterogeneity and plasticity is crucial for comprehending AS pathogenesis.
Purpose of the Study:
- To review the latest advancements in single-cell transcriptomic technologies and their impact on AS research.
- To highlight novel T-cell subsets and their roles in atherosclerotic plaque development.
Main Methods:
- Consolidation of recent findings from single-cell transcriptomic studies.
- Application of spatial mapping and temporal analyses to study T-cell distribution and function.
- Integration of multiomics approaches and spatial transcriptomics.
Main Results:
- Identification of previously unrecognized T-cell subsets in atherosclerotic lesions with unique transcriptional profiles.
- Demonstration of T-cell adaptability influenced by the microenvironment and compartment-specific distributions.
- Delineation of transitional states between T-cell lineages, indicating the role of local inflammatory signals.
Conclusions:
- Single-cell RNA sequencing has uncovered significant T-cell heterogeneity and plasticity in AS immunology.
- These discoveries provide a foundation for developing targeted immunotherapies and identifying biomarkers for AS.
- Advancements promise to enhance precision medicine approaches for atherosclerosis patients.
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation
Overview
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
